ALDH1A1 and cancer: Figure 5A,B reveals that DDC, a well-known ALDH1 inhibitor and oxidizing agent, altered redox balance in both normal and cancer by increasing intercellular reactive species that caused oxidation of DCFH2 to DCF by ≈30%.